National Research Price To Book vs. EBITDA
| NRC Stock | USD 19.35 0.15 0.77% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.46 | 0.5833 |
|
| |||||
| Net Profit Margin | 0.14 | 0.2084 |
|
| |||||
| Operating Profit Margin | 0.21 | 0.2695 |
|
| |||||
| Pretax Profit Margin | 0.2 | 0.269 |
|
| |||||
| Return On Assets | 0.2 | 0.253 |
|
| |||||
| Return On Equity | 0.48 | 0.6326 |
|
|
For National Research profitability analysis, we use financial ratios and fundamental drivers that measure the ability of National Research to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well National Research Corp utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between National Research's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of National Research Corp over time as well as its relative position and ranking within its peers.
National |
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of National Research. If investors know National will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about National Research listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.25) | Dividend Share 0.48 | Earnings Share 1.12 | Revenue Per Share 6.013 | Quarterly Revenue Growth (0.06) |
The market value of National Research Corp is measured differently than its book value, which is the value of National that is recorded on the company's balance sheet. Investors also form their own opinion of National Research's value that differs from its market value or its book value, called intrinsic value, which is National Research's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because National Research's market value can be influenced by many factors that don't directly affect National Research's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between National Research's value and its price as these two are different measures arrived at by different means. Investors typically determine if National Research is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, National Research's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
National Research Corp EBITDA vs. Price To Book Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining National Research's current stock value. Our valuation model uses many indicators to compare National Research value to that of its competitors to determine the firm's financial worth. National Research Corp is considered to be number one stock in price to book category among its peers. It also is considered to be number one stock in ebitda category among its peers totaling about 3,477,942 of EBITDA per Price To Book. At present, National Research's EBITDA is projected to increase significantly based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the National Research's earnings, one of the primary drivers of an investment's value.National Research's Earnings Breakdown by Geography
National EBITDA vs. Price To Book
Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
National Research |
| = | 13.22 X |
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
National Research |
| = | 45.98 M |
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
National EBITDA Comparison
National Research is currently under evaluation in ebitda category among its peers.
National Research Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in National Research, profitability is also one of the essential criteria for including it into their portfolios because, without profit, National Research will eventually generate negative long term returns. The profitability progress is the general direction of National Research's change in net profit over the period of time. It can combine multiple indicators of National Research, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Operating Income | 40 M | 42 M | |
| Income Before Tax | 40 M | 42 M | |
| Total Other Income Expense Net | -83 K | -87.2 K | |
| Net Income | 31 M | 32.5 M | |
| Income Tax Expense | 9 M | 5.5 M | |
| Net Income Applicable To Common Shares | 36.6 M | 20.5 M | |
| Net Income From Continuing Ops | 28.8 M | 28.2 M | |
| Non Operating Income Net Other | -2.3 M | -2.2 M | |
| Interest Income | 913 K | 958.6 K | |
| Net Interest Income | 33 K | 34.6 K | |
| Change To Netincome | -27 K | -25.6 K | |
| Net Income Per Share | 1.26 | 0.67 | |
| Income Quality | 1.23 | 1.62 | |
| Net Income Per E B T | 0.78 | 0.56 |
National Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on National Research. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of National Research position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the National Research's important profitability drivers and their relationship over time.
Use National Research in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if National Research position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in National Research will appreciate offsetting losses from the drop in the long position's value.National Research Pair Trading
National Research Corp Pair Trading Analysis
The ability to find closely correlated positions to National Research could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace National Research when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back National Research - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling National Research Corp to buy it.
The correlation of National Research is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as National Research moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if National Research Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for National Research can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your National Research position
In addition to having National Research in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Giant Impact Thematic Idea Now
Giant Impact
An experimental equal-weighted decomposition of large high potential stocks based on Macroaxis scoring framework. The Giant Impact theme has 44 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Giant Impact Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Correlation Analysis. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
To fully project National Research's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of National Research Corp at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include National Research's income statement, its balance sheet, and the statement of cash flows.